Fig. 4From: Concurrent hyperfractionated chemoradiotherapy for head and neck squamous cell carcinoma: the prognostic impact of the overall treatment time and completion rates of chemotherapyThe schedules of concurrent chemoradiotherapy using hyperfractionated radiotherapy and carboplatinBack to article page